Tim D. Bovee
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 2%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Bioactive Compounds and Antitumor Agents 2
-
- Cell Adhesion Molecules Research 3
- Co-authors
- Svetlana O. DoroninaPeter D. SenterBrian E. TokiBrian A. MendelsohnDamon L. MeyerAlan F. WahlCharles G. CervenyMartha E. Anderson
- Journals
- Nature Biotechnology (3 papers)Cancer Research (3 papers)Bioconjugate Chemistry (2 papers)Molecular Cancer Therapeutics (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United States
In The Last Decade
Tim D. Bovee
10 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Radiology, Nuclear Medicine and Imaging 1.4k
- Oncology 1.5k
- Immunology and Allergy 105
- Molecular Biology 881
- Organic Chemistry 314
Countries citing papers authored by Tim D. Bovee
This map shows the geographic impact of Tim D. Bovee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim D. Bovee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim D. Bovee more than expected).
Fields of papers citing papers by Tim D. Bovee
This network shows the impact of papers produced by Tim D. Bovee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim D. Bovee. The network helps show where Tim D. Bovee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tim D. Bovee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2020 | 19 | |
| 4 | Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index Hit paper breakdown → | 2015 | 390 |
| 5 | Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates Hit paper breakdown → | 2014 | 358 |
| 6 | 2014 | 4 | |
| 7 | 2013 | 3 | |
| 8 | 2008 | 133 | |
| 9 | 2005 | 383 | |
| 10 | Development of potent monoclonal antibody auristatin conjugates for cancer therapy Hit paper breakdown → | 2003 | 903 |
About Tim D. Bovee
Tim D. Bovee is a scholar working on Toxicology, Immunology and Allergy, Radiology, Nuclear Medicine and Imaging, Oncology and Complementary and alternative medicine, having authored 10 papers that have together received 2.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Cell Adhesion Molecules Research (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Cancer Treatment and Pharmacology (2 papers), Peptidase Inhibition and Analysis (2 papers), Bioactive natural compounds (1 paper) and Phytochemistry and Biological Activities (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.4k citations), Oncology (1.5k citations), Immunology and Allergy (105 citations), Molecular Biology (881 citations) and Organic Chemistry (314 citations). Tim D. Bovee has collaborated with scholars based in United States. Frequent co-authors include Svetlana O. Doronina, Peter D. Senter, Brian E. Toki, Brian A. Mendelsohn, Damon L. Meyer, Alan F. Wahl, Charles G. Cerveny, Martha E. Anderson, Robert P. Lyon and Joshua H. Hunter. Their work appears in journals such as Nature Biotechnology, Cancer Research, Bioconjugate Chemistry, Molecular Cancer Therapeutics and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.